On Thursday, April 28, American company Moderna announced that it had applied to the FDA for approval of the company’s coronavirus vaccine for children under the age of six.
If US regulator approval is granted, Moderna will be the first company to vaccinate children under the age of five against the coronavirus.
In March, Moderna published the results of clinical trials of the vaccine, which found that the vaccine elicited the same immune response in children under six years of age as it does in adults.
Recall that the coronavirus vaccine from Pfizer and BioNTech is approved for use in children aged five years and older. However, when the vaccine was tested on children between two and four years of age, the test results showed that children in this age group had a much weaker immune response than adults.
In this regard, Pfizer announced that it is conducting new trials of the vaccine, which should be completed before the end of April.